Aptevo Therapeutics logo

Aptevo Therapeutics Share Price (NASDAQ: APVO)

$1.64

-0.06

(-3.53%)

Last updated on

Check the interactive Aptevo Therapeutics Stock chart to analyse performance

Aptevo Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.63
    Today's High:$1.70

    Day's Volatility :4.12%

  • 52 Weeks Low:$1.63
    52 Weeks High:$381.10

    52 Weeks Volatility :99.57%

Aptevo Therapeutics Stock Returns

PeriodAptevo Therapeutics IncIndex (Russel 2000)
3 Months
-65.62%
0.0%
6 Months
-97.35%
0.0%
1 Year
-99.36%
0.0%
3 Years
-100.0%
-4.7%

Aptevo Therapeutics Inc Key Stats

Check Aptevo Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.7
Open
$1.67
Today's High
$1.7
Today's Low
$1.63
Market Capitalization
$5.6M
Today's Volume
$102.9K
52 Week High
$381.1
52 Week Low
$1.63
Revenue TTM
$0.0
EBITDA
$-24.0M
Earnings Per Share (EPS)
$2680.54
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-437.34%

Stock Returns calculator for Aptevo Therapeutics Stock including INR - Dollar returns

The Aptevo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aptevo Therapeutics investment value today

Current value as on today

₹5,900

Returns

₹94,100

(-94.1%)

Returns from Aptevo Therapeutics Stock

₹99,384 (-99.38%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Aptevo Therapeutics Stock

-26%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Aptevo Therapeutics Stock from India on INDmoney has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aptevo Therapeutics Inc

  • Name

    Holdings %

  • Tower Research Capital LLC

    0.04%

  • Geode Capital Management, LLC

    0.02%

Analyst Recommendation on Aptevo Therapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Aptevo Therapeutics(by analysts ranked 0 to 5 stars)

Aptevo Therapeutics Share Price Target

What analysts predicted

Upside of 25509.76%

Target:

$420.00

Current:

$1.64

Aptevo Therapeutics share price target is $420.00, a slight Upside of 25509.76% compared to current price of $1.64 as per analysts' prediction.

Aptevo Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, APVO stock has moved down by -17.2%
  • APVO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 169.3%
  • APVO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.6%

Aptevo Therapeutics Technicals Summary

Sell

Neutral

Buy

Aptevo Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Aptevo Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aptevo Therapeutics Inc logo
-41.22%
-97.35%
-99.36%
-100.0%
-100.0%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Aptevo Therapeutics Inc

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Organization
Aptevo Therapeutics
Employees
37
CEO
Mr. Marvin L. White
Industry
Health Technology

Key Management of Aptevo Therapeutics Inc

NameTitle
Mr. Marvin L. White
President, CEO & Director
Mr. Jeffrey G. Lamothe CA
Executive VP & COO
Ms. SoYoung Kwon J.D., LL.M.
Corporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs
Ms. Daphne L. Taylor CPA
Senior VP & CFO
Dr. Dirk Huebner M.D.
Chief Medical Officer

Important FAQs about investing in APVO Stock from India :

What is Aptevo Therapeutics share price today?

Aptevo Therapeutics share price today is $1.64 as on at the close of the market. Aptevo Therapeutics share today touched a day high of $1.70 and a low of $1.63.

What is the 52 week high and 52 week low for Aptevo Therapeutics share?

Aptevo Therapeutics share touched a 52 week high of $381.10 and a 52 week low of $1.63. Aptevo Therapeutics stock price today i.e. is closed at $1.64, lower by 99.57% versus the 52 week high.

How to invest in Aptevo Therapeutics Stock (APVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aptevo Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aptevo Therapeutics Shares that will get you 0.9146 shares as per Aptevo Therapeutics share price of $1.64 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aptevo Therapeutics Stock (APVO) from India?

Indian investors can start investing in Aptevo Therapeutics (APVO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aptevo Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Aptevo Therapeutics share’s latest price of $1.64 as on August 30, 2025 at 1:29 am IST, you will get 6.0976 shares of Aptevo Therapeutics. Learn more about fractional shares .

What are the returns that Aptevo Therapeutics has given to Indian investors in the last 5 years?

Aptevo Therapeutics stock has given -100.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?